trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Tshuikina M et al. Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma. 2008 Exp. Hematol. pmid:18922617
Liu F et al. Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. 2008 J. Mol. Cell. Cardiol. pmid:18926829
Bao Y et al. Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells. 2009 Atherosclerosis pmid:18930459
Gu Z et al. Promoter hypermethylation is not the major mechanism for inactivation of the FBXW7 beta-form in human gliomas. 2008 Genes Genet. Syst. pmid:18931460
Bigl M et al. Aberrant methylation of human L- and M-fructose 1,6-bisphosphatase genes in cancer. 2008 Biochem. Biophys. Res. Commun. pmid:18938139
Hayashi K et al. Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. 2008 Cell Stem Cell pmid:18940731
Ridolfi E et al. Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs. 2008 Br. J. Cancer pmid:18941460
Katsura T et al. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells. 2009 Cancer Gene Ther. pmid:18949013
Park H et al. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. 2008 Int. J. Mol. Med. pmid:18949380
Lin YC et al. Effects of trichostatin A on neuronal mu-opioid receptor gene expression. 2008 Brain Res. pmid:18950606
Wallace DM and Cotter TG Histone deacetylase activity in conjunction with E2F-1 and p53 regulates Apaf-1 expression in 661W cells and the retina. 2009 J. Neurosci. Res. pmid:18951482
Chittur SV et al. Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism. 2008 BMC Genomics pmid:18959802
Oger F et al. The class I histone deacetylases of the platyhelminth parasite Schistosoma mansoni. 2008 Biochem. Biophys. Res. Commun. pmid:18977200
Albertus DL et al. AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma. 2008 J Thorac Oncol pmid:18978557
Chou CW and Chen CC HDAC inhibition upregulates the expression of angiostatic ADAMTS1. 2008 FEBS Lett. pmid:19007777
Hostetter CL et al. Timing is everything: order of administration of 5-aza 2' deoxycytidine, trichostatin A and tamoxifen changes estrogen receptor mRNA expression and cell sensitivity. 2009 Cancer Lett. pmid:19013015
Heo H et al. Suppression of caspase-11 expression by histone deacetylase inhibitors. 2009 Biochem. Biophys. Res. Commun. pmid:19013432
McCulloch MW et al. Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivatives. 2009 Bioorg. Med. Chem. pmid:19022675
Noh EJ et al. An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner. 2009 Biochem. Biophys. Res. Commun. pmid:19038231
Kong X et al. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells. 2009 J. Mol. Cell. Cardiol. pmid:19041327
Setiadi AF et al. Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors. 2008 Cancer Res. pmid:19047136
Mizumoto S et al. The developmental potential of parthenogenetic and somatic cell nuclear-transferred rat oocytes in vitro. 2008 Cloning Stem Cells pmid:19049415
Slack MD et al. Characterizing heterogeneous cellular responses to perturbations. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:19052231
Dowling DP et al. Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors. 2008 Biochemistry pmid:19053282
Gao J et al. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site. 2009 Glia pmid:19062177
Ishii T et al. [Epigenetic regulation in alcohol-related brain damage]. 2008 Nihon Arukoru Yakubutsu Igakkai Zasshi pmid:19068777
Rossi M et al. Caspase cleavage of Itch in chronic lymphocytic leukemia cells. 2009 Biochem. Biophys. Res. Commun. pmid:19073138
Gray SG et al. Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells. 2008 Clin Lung Cancer pmid:19073520
Pollack BP et al. Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation. 2009 May-Jun Photochem. Photobiol. pmid:19076306
Meng CF et al. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP]. 2008 Ai Zheng pmid:19079988
Usami M et al. Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. 2008 Nutr Res pmid:19083427
Kishigami S and Wakayama T Somatic cell nuclear transfer in the mouse. 2009 Methods Mol. Biol. pmid:19085136
Jiang SJ et al. [Effects of trichostatin A and paclitaxel on apoptosis and microtubule stabilization in endometrial carcinoma cells: an in vitro research]. 2008 Zhonghua Yi Xue Za Zhi pmid:19087722
Azzi A et al. Schistosoma mansoni: developmental arrest of miracidia treated with histone deacetylase inhibitors. 2009 Exp. Parasitol. pmid:19094990
Hambach L et al. Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy. 2009 Blood pmid:19096014
Sibinga NE Stable protein, unstable plaque? 2009 J. Mol. Cell. Cardiol. pmid:19101562
Niu F et al. Trichostatin A enhances OGD-astrocyte viability by inhibiting inflammatory reaction mediated by NF-kappaB. 2009 Brain Res. Bull. pmid:19103266
Santiago A et al. Identification of two independent SUMO-interacting motifs in Daxx: evolutionary conservation from Drosophila to humans and their biochemical functions. 2009 Cell Cycle pmid:19106612
Wang X et al. Inhibition of histone deacetylases antagonized FGF2 and IL-1beta effects on MMP expression in human articular chondrocytes. 2009 Growth Factors pmid:19107653
Trunzer M et al. Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation. 2009 J. Med. Chem. pmid:19108654
Smil DV et al. Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors. 2009 Bioorg. Med. Chem. Lett. pmid:19111466
Zhang S et al. Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3. 2008 Exp. Oncol. pmid:19112422
Kim TY et al. Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells. 2008 Exp. Mol. Med. pmid:19116449
Cowell RM et al. Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells. 2009 Biochem. Biophys. Res. Commun. pmid:19118529
Wiesen JL and Tomasi TB Dicer is regulated by cellular stresses and interferons. 2009 Mol. Immunol. pmid:19118902
Togi S et al. HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A. 2009 Biochem. Biophys. Res. Commun. pmid:19121623
Dje N'Guessan P et al. Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19122173
Zhou Q et al. Histone deacetylase inhibitors blocked activation and caused senescence of corneal stromal cells. 2008 Mol. Vis. pmid:19122829
Yamada N et al. Promoter CpG methylation in cancer cells contributes to the regulation of MUC4. 2009 Br. J. Cancer pmid:19127263
Giustiniani J et al. Tubulin acetylation favors Hsp90 recruitment to microtubules and stimulates the signaling function of the Hsp90 clients Akt/PKB and p53. 2009 Cell. Signal. pmid:19136058
Chen Y et al. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. 2009 Eur J Med Chem pmid:19136179
Glenn DJ et al. Endothelin-stimulated human B-type natriuretic peptide gene expression is mediated by Yin Yang 1 in association with histone deacetylase 2. 2009 Hypertension pmid:19139378
Li X and Bai XZ [NF-kappaB modulates activation of the BMP-2 gene by trichostatin A]. 2008 Nov-Dec Mol. Biol. (Mosk.) pmid:19140318
Kir'ianov GI et al. [Nucleosome positioning within neomycinphosphotransferase gene (NPTII) on yeast plasmid in repressed and active state]. 2008 Nov-Dec Mol. Biol. (Mosk.) pmid:19140324
Golyshev SA et al. [The role of DNA methylation and histone modifications in structural maintainance of heterochromatin domains (chromocenters)]. 2008 Tsitologiia pmid:19140344
Chen FQ et al. Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea. 2009 J. Neurochem. pmid:19141081
Zhao W et al. Histone deacetylase inhibitor, trichostatin A, affects gene expression patterns during morphogenesis of chicken limb buds in vivo. 2009 Cells Tissues Organs (Print) pmid:19147985
Chen Z et al. BCL11A represses HBG transcription in K562 cells. 2009 Mar-Apr Blood Cells Mol. Dis. pmid:19153051
Kekatpure VD et al. HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling. 2009 J. Biol. Chem. pmid:19158084
Sutcliffe EL et al. Dynamic histone variant exchange accompanies gene induction in T cells. 2009 Mol. Cell. Biol. pmid:19158270
Bagui TK et al. Inhibition of p27Kip1 gene transcription by mitogens. 2009 Cell Cycle pmid:19158484
Chakravorty M et al. IL1B promoter polymorphism regulates the expression of gastric acid stimulating hormone gastrin. 2009 Int. J. Biochem. Cell Biol. pmid:19166966
Sharma A et al. Trichostatin a inhibits corneal haze in vitro and in vivo. 2009 Invest. Ophthalmol. Vis. Sci. pmid:19168895
Zubia A et al. Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity. 2009 Oncogene pmid:19169274
Yeh JR et al. Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. 2009 Nat. Chem. Biol. pmid:19172146
Wang L et al. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance. 2009 Mar-Apr Immunol. Cell Biol. pmid:19172156
Popova EY et al. Chromatin condensation in terminally differentiating mouse erythroblasts does not involve special architectural proteins but depends on histone deacetylation. 2009 Chromosome Res. pmid:19172406
Tsuji Y et al. The developmental potential of mouse somatic cell nuclear-transferred oocytes treated with trichostatin A and 5-aza-2'-deoxycytidine. 2009 Zygote pmid:19175955
Gavin DP et al. Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population. 2009 J Psychiatr Res pmid:19187942
Meng Q et al. Live birth of somatic cell-cloned rabbits following trichostatin A treatment and cotransfer of parthenogenetic embryos. 2009 Cloning Stem Cells pmid:19196041
Maalouf WE et al. Trichostatin A treatment of cloned mouse embryos improves constitutive heterochromatin remodeling as well as developmental potential to term. 2009 BMC Dev. Biol. pmid:19210795
Sakurai T et al. Induction of endogenous interferon tau gene transcription by CDX2 and high acetylation in bovine nontrophoblast cells. 2009 Biol. Reprod. pmid:19211809
Deng G et al. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs. 2009 Clin. Cancer Res. pmid:19223499
Halaban R et al. Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. 2009 PLoS ONE pmid:19234609
Shao GB et al. Effect of trychostatin A treatment on gene expression in cloned mouse embryos. 2009 Theriogenology pmid:19246084
Zhang F et al. Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells. 2009 Cancer Biol. Ther. pmid:19270532
Tan HH and Porter AG p21(WAF1) negatively regulates DNMT1 expression in mammalian cells. 2009 Biochem. Biophys. Res. Commun. pmid:19275888
Mittal MK et al. Mode of action of the retrogene product SNAI1P, a SNAIL homolog, in human breast cancer cells. 2010 Mol. Biol. Rep. pmid:19277896
Lu SC et al. The essential role of Oct-2 in LPS-induced expression of iNOS in RAW 264.7 macrophages and its regulation by trichostatin A. 2009 Am. J. Physiol., Cell Physiol. pmid:19279235
Luo SF et al. Activation of ROS/NF-kappaB and Ca2+/CaM kinase II are necessary for VCAM-1 induction in IL-1beta-treated human tracheal smooth muscle cells. 2009 Toxicol. Appl. Pharmacol. pmid:19281832
Giannini G et al. N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC) inhibitors. 2009 Bioorg. Med. Chem. Lett. pmid:19285395
Suo L et al. Changes in acetylation on lysine 12 of histone H4 (acH4K12) of murine oocytes during maternal aging may affect fertilization and subsequent embryo development. 2010 Fertil. Steril. pmid:19285668
Seo J et al. Differential expression of stromal cell-derived factor 1 in human brain microvascular endothelial cells and pericytes involves histone modifications. 2009 Biochem. Biophys. Res. Commun. pmid:19289100
Cecconi D et al. Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. 2009 Proteomics pmid:19294695
Chen J et al. E1A has no effect on LPS-induced IL-6 secretion in rat alveolar epithelial cells. 2009 Respiration pmid:19299891
Ueda JY et al. JBIR-17, a novel trichostatin analog from Streptomyces sp. 26634. 2009 J. Antibiot. pmid:19300468
Noro R et al. The anticancer effect of histone deacetylase inhibitors and combination with the cytotoxic agents in lung cancer cells: biological analyses for future clinical application. 2009 J Nippon Med Sch pmid:19305113
Patel V et al. Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. 2009 J. Med. Chem. pmid:19317450
García-Villegas R et al. Identification and functional characterization of the promoter of the mouse sodium-activated sodium channel Na(x) gene (Scn7a). 2009 J. Neurosci. Res. pmid:19326446
Derks S et al. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. 2009 Carcinogenesis pmid:19329758
Liu X et al. The improvement of adenovirus vector production by increased expression of coxsackie adenovirus receptor. 2009 Biotechnol. Lett. pmid:19330491
Hollosi P et al. Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells. 2009 Int. J. Cancer pmid:19330836
Yap OW et al. Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells. 2009 Anticancer Res. pmid:19331143
Yang X et al. CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells. 2009 PLoS ONE pmid:19340297
Slattery EL et al. Epigenetic influences on sensory regeneration: histone deacetylases regulate supporting cell proliferation in the avian utricle. 2009 J. Assoc. Res. Otolaryngol. pmid:19340485
Vilar E et al. Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway. 2009 Clin. Cancer Res. pmid:19351759
Ikeda S et al. Enhancement of histone acetylation by trichostatin A during in vitro fertilization of bovine oocytes affects cell number of the inner cell mass of the resulting blastocysts. 2009 Zygote pmid:19356267
Morita K et al. Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells. 2009 J. Neurosci. Res. pmid:19360904
von Burstin J et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. 2009 Gastroenterology pmid:19362090
Cunneen TS et al. In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. 2009 Arch. Ophthalmol. pmid:19365017